PMC:7534206 / 3653-4619 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":451,"end":456},"obj":"Body_part"},{"id":"T5","span":{"begin":466,"end":470},"obj":"Body_part"},{"id":"T6","span":{"begin":480,"end":485},"obj":"Body_part"},{"id":"T7","span":{"begin":495,"end":501},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma7203"}],"text":"Institutional review board of Thomas Jefferson University Hospital (12D:534) approved the study protocol and waived the need for informed consent. A retrospective analysis was conducted across two institutions between 20 March and 20 May 2020. Twenty-two patients were identified with the diagnosis of acute cerebrovascular disease and COVID-19 infection. Medical charts were queried for baseline patient characteristics (age, gender), comorbidities (heart disease, lung disease, liver disease, kidney disease, atrial fibrillation, and diabetes mellitus), COVID-19 symptoms (fever, cough, pneumonia), duration between COVID-19 symptoms and the neurological manifestation, cerebrovascular insult (aneurysm rupture, intracranial hemorrhage, and stroke), National Institute of Health Stroke Scale (NIHSS) at presentation, procedure detail (duration from the sheath into sheath out and thrombolysis in cerebral infarction (TICI) score, laboratory results, and mortality."}

LitCovid-PD-UBERON

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T8","span":{"begin":451,"end":456},"obj":"Body_part"},{"id":"T9","span":{"begin":466,"end":470},"obj":"Body_part"},{"id":"T10","span":{"begin":480,"end":485},"obj":"Body_part"},{"id":"T11","span":{"begin":495,"end":501},"obj":"Body_part"},{"id":"T12","span":{"begin":788,"end":793},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"}],"text":"Institutional review board of Thomas Jefferson University Hospital (12D:534) approved the study protocol and waived the need for informed consent. A retrospective analysis was conducted across two institutions between 20 March and 20 May 2020. Twenty-two patients were identified with the diagnosis of acute cerebrovascular disease and COVID-19 infection. Medical charts were queried for baseline patient characteristics (age, gender), comorbidities (heart disease, lung disease, liver disease, kidney disease, atrial fibrillation, and diabetes mellitus), COVID-19 symptoms (fever, cough, pneumonia), duration between COVID-19 symptoms and the neurological manifestation, cerebrovascular insult (aneurysm rupture, intracranial hemorrhage, and stroke), National Institute of Health Stroke Scale (NIHSS) at presentation, procedure detail (duration from the sheath into sheath out and thrombolysis in cerebral infarction (TICI) score, laboratory results, and mortality."}

LitCovid-PD-MONDO

LitCovid-PD-CLO

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T34","span":{"begin":147,"end":148},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T35","span":{"begin":451,"end":456},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T36","span":{"begin":451,"end":456},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T37","span":{"begin":451,"end":456},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T38","span":{"begin":451,"end":456},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T39","span":{"begin":466,"end":470},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T40","span":{"begin":466,"end":470},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T41","span":{"begin":480,"end":485},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T42","span":{"begin":480,"end":485},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T43","span":{"begin":495,"end":501},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T44","span":{"begin":495,"end":501},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T45","span":{"begin":495,"end":501},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"}],"text":"Institutional review board of Thomas Jefferson University Hospital (12D:534) approved the study protocol and waived the need for informed consent. A retrospective analysis was conducted across two institutions between 20 March and 20 May 2020. Twenty-two patients were identified with the diagnosis of acute cerebrovascular disease and COVID-19 infection. Medical charts were queried for baseline patient characteristics (age, gender), comorbidities (heart disease, lung disease, liver disease, kidney disease, atrial fibrillation, and diabetes mellitus), COVID-19 symptoms (fever, cough, pneumonia), duration between COVID-19 symptoms and the neurological manifestation, cerebrovascular insult (aneurysm rupture, intracranial hemorrhage, and stroke), National Institute of Health Stroke Scale (NIHSS) at presentation, procedure detail (duration from the sheath into sheath out and thrombolysis in cerebral infarction (TICI) score, laboratory results, and mortality."}

LitCovid-PD-HP

{"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":466,"end":478},"obj":"Phenotype"},{"id":"T9","span":{"begin":480,"end":493},"obj":"Phenotype"},{"id":"T10","span":{"begin":495,"end":509},"obj":"Phenotype"},{"id":"T11","span":{"begin":511,"end":530},"obj":"Phenotype"},{"id":"T12","span":{"begin":536,"end":553},"obj":"Phenotype"},{"id":"T13","span":{"begin":575,"end":580},"obj":"Phenotype"},{"id":"T14","span":{"begin":582,"end":587},"obj":"Phenotype"},{"id":"T15","span":{"begin":589,"end":598},"obj":"Phenotype"},{"id":"T16","span":{"begin":696,"end":704},"obj":"Phenotype"},{"id":"T17","span":{"begin":714,"end":737},"obj":"Phenotype"},{"id":"T18","span":{"begin":743,"end":749},"obj":"Phenotype"},{"id":"T19","span":{"begin":781,"end":787},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002088"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0001392"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0000112"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0005110"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0000819"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0002617"},{"id":"A17","pred":"hp_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/HP_0002170"},{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0001297"},{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0001297"}],"text":"Institutional review board of Thomas Jefferson University Hospital (12D:534) approved the study protocol and waived the need for informed consent. A retrospective analysis was conducted across two institutions between 20 March and 20 May 2020. Twenty-two patients were identified with the diagnosis of acute cerebrovascular disease and COVID-19 infection. Medical charts were queried for baseline patient characteristics (age, gender), comorbidities (heart disease, lung disease, liver disease, kidney disease, atrial fibrillation, and diabetes mellitus), COVID-19 symptoms (fever, cough, pneumonia), duration between COVID-19 symptoms and the neurological manifestation, cerebrovascular insult (aneurysm rupture, intracranial hemorrhage, and stroke), National Institute of Health Stroke Scale (NIHSS) at presentation, procedure detail (duration from the sheath into sheath out and thrombolysis in cerebral infarction (TICI) score, laboratory results, and mortality."}

LitCovid-sentences

{"project":"LitCovid-sentences","denotations":[{"id":"T33","span":{"begin":0,"end":146},"obj":"Sentence"},{"id":"T34","span":{"begin":147,"end":243},"obj":"Sentence"},{"id":"T35","span":{"begin":244,"end":355},"obj":"Sentence"},{"id":"T36","span":{"begin":356,"end":966},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Institutional review board of Thomas Jefferson University Hospital (12D:534) approved the study protocol and waived the need for informed consent. A retrospective analysis was conducted across two institutions between 20 March and 20 May 2020. Twenty-two patients were identified with the diagnosis of acute cerebrovascular disease and COVID-19 infection. Medical charts were queried for baseline patient characteristics (age, gender), comorbidities (heart disease, lung disease, liver disease, kidney disease, atrial fibrillation, and diabetes mellitus), COVID-19 symptoms (fever, cough, pneumonia), duration between COVID-19 symptoms and the neurological manifestation, cerebrovascular insult (aneurysm rupture, intracranial hemorrhage, and stroke), National Institute of Health Stroke Scale (NIHSS) at presentation, procedure detail (duration from the sheath into sheath out and thrombolysis in cerebral infarction (TICI) score, laboratory results, and mortality."}

LitCovid-PubTator

{"project":"LitCovid-PubTator","denotations":[{"id":"121","span":{"begin":255,"end":263},"obj":"Species"},{"id":"122","span":{"begin":397,"end":404},"obj":"Species"},{"id":"123","span":{"begin":302,"end":331},"obj":"Disease"},{"id":"124","span":{"begin":336,"end":344},"obj":"Disease"},{"id":"125","span":{"begin":345,"end":354},"obj":"Disease"}],"attributes":[{"id":"A121","pred":"tao:has_database_id","subj":"121","obj":"Tax:9606"},{"id":"A122","pred":"tao:has_database_id","subj":"122","obj":"Tax:9606"},{"id":"A123","pred":"tao:has_database_id","subj":"123","obj":"MESH:D002561"},{"id":"A124","pred":"tao:has_database_id","subj":"124","obj":"MESH:C000657245"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Institutional review board of Thomas Jefferson University Hospital (12D:534) approved the study protocol and waived the need for informed consent. A retrospective analysis was conducted across two institutions between 20 March and 20 May 2020. Twenty-two patients were identified with the diagnosis of acute cerebrovascular disease and COVID-19 infection. Medical charts were queried for baseline patient characteristics (age, gender), comorbidities (heart disease, lung disease, liver disease, kidney disease, atrial fibrillation, and diabetes mellitus), COVID-19 symptoms (fever, cough, pneumonia), duration between COVID-19 symptoms and the neurological manifestation, cerebrovascular insult (aneurysm rupture, intracranial hemorrhage, and stroke), National Institute of Health Stroke Scale (NIHSS) at presentation, procedure detail (duration from the sheath into sheath out and thrombolysis in cerebral infarction (TICI) score, laboratory results, and mortality."}